Milestone Pharmaceuticals (MIST) Receivables - Other (2018 - 2026)

Milestone Pharmaceuticals (MIST) has reported Receivables - Other for 9 consecutive years, with $726000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Other fell 21.43% year-over-year to $726000.0; the trailing twelve-month figure through Jun 2026 stood at $726000.0 (down 21.43% YoY), and the FY2025 full-year result was $1.6 million, up 195.81% from the prior year.
• Receivables - Other retreated to $726000.0 in Q2 2026 per MIST's latest filing, from $1.4 million in the prior quarter.
• Across five years, Receivables - Other topped out at $1.7 million in Q4 2023 and bottomed at -$1.8 million in Q1 2024.
• Historically, Receivables - Other has averaged $754555.6 across 5 years, with a median of $825000.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other jumped 1076.32% in 2022, then slumped 358.65% in 2024.
• Over 5 years, Receivables - Other stood at $447000.0 in 2022, then jumped by 277.4% to $1.7 million in 2023, then tumbled by 83.46% to $279000.0 in 2024, then soared by 239.07% to $946000.0 in 2025, then fell by 23.26% to $726000.0 in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $726000.0, $1.4 million, and $946000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.